| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2008;118:1785-1792.)
© 2008 American Heart Association, Inc.
Cardiovascular Surgery |
From the Division of Cardiac Surgery (A.K., M.R.), University of Ottawa Heart Institute, Ottawa, Canada, and the Division of Pharmacoepidemiology and Pharmacoeconomics (M.A.B., R.L., D.H.S., N.K.C.), Brigham and Womens Hospital, Harvard Medical School, Boston, Mass.
Correspondence to Niteesh K. Choudhry, MD, PhD, Brigham and Womens Hospital, 1620 Tremont St, Suite 3030, Boston, MA 02120. E-mail nchoudhry{at}partners.org
Received August 31, 2007; accepted August 29, 2008.
Background— The benefits of statins have been demonstrated for patients with a remote history of coronary artery bypass grafting (CABG); however, no investigation to date has evaluated whether initiation of statin therapy in the early months after surgery improves clinical outcomes.
Methods and Results— A retrospective cohort of 7503 Medicare patients
65 years of age who underwent CABG (1995–2003) was assembled by use of linked hospital and pharmacy claims data. Rates of all-cause mortality and major adverse cardiovascular events were compared between patients who were (n=1745) and were not (n=5788) prescribed statins within 1 month of CABG discharge. Additional analyses evaluated the impact of statin initiation between 1 and 6 months after surgery. Multivariable and propensity score analysis demonstrated that statin use within 1 month of CABG discharge independently reduced the risk of all-cause mortality (adjusted hazard ratio 0.82, 95% confidence interval 0.72 to 0.94) compared with no statin use. Similarly, statin use within 1 month of CABG discharge independently reduced the risk of major adverse cardiovascular events (adjusted hazard ratio 0.89, 95% confidence interval 0.81 to 0.98). Initiation of statin therapy between 1 and 6 months after CABG discharge was also associated with reductions in major adverse cardiovascular events and mortality; however, outcome rates between early (
1 month after CABG) and delayed (1 to 6 months after CABG) statin initiation were not significantly different.
Conclusions— Statin therapy initiated in the early months after hospital discharge independently reduces all-cause mortality and major adverse cardiovascular events after CABG. These findings validate the widespread practice of prescribing long-term statin therapy after CABG.
Related Article:
This article has been cited by other articles:
![]() |
M. Carrier, M. Cossette, M. Pellerin, Y. Hebert, D. Bouchard, R. Cartier, P. Demers, H. Jeanmart, P. Page, and L. P. Perrault Statin treatment equalizes long-term survival between patients with single and bilateral internal thoracic artery grafts. Ann. Thorac. Surg., September 1, 2009; 88(3): 789 - 795. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. K. Choudhry Copayment Levels and Medication Adherence: Less Is More Circulation, January 27, 2009; 119(3): 365 - 367. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |